Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2021-03-18 2021-04-29 135952
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2020-09-24 2020-11-12 125007
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-12-13 2025-10-30 245615
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-12-19 2025-10-30 246118
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-11-28 2025-10-30 244078
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2023-04-27 2023-06-27 190713
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2024-10-11 2024-11-01 240043
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2020-11-27 2020-12-17 129050
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2024-10-11 2024-11-08 240040
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-20 2023-06-27 195844
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-22 2021-09-02 142908
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-01 2023-06-09 176818
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2020-01-30 2020-03-19 104902
TEVA-TOPILENE 0.05% CREAM Resolved 2025-09-25 2025-11-20 267862
TEVA-TOPILENE 0.5MG LOTION Resolved 2020-01-24 2020-04-02 104365
TEVA-TOPILENE 0.05% OINTMENT Actual shortage 2024-08-30 2025-09-25 236356
TEVA-TOPILENE 0.05% LOTION Resolved 2023-06-19 2023-07-05 195579
TEVA-TOPILENE 0.05% LOTION Actual shortage 2025-11-20 2026-01-15 272292
TEVA-TOPILENE 0.05% CREAM Resolved 2020-04-10 2020-04-23 111851
TEVA-TOPILENE 0.05% CREAM Resolved 2024-02-08 2024-07-18 218949
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
IRINOTECAN FOR INJECTION 20MG SOLUTION Discontinued 2025-05-28 2025-05-28 258762
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-05-28 2025-05-28 258481
METHOTREXATE SODIUM INJECTION 25MG SOLUTION Discontinued 2025-04-25 2025-04-25 255818
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 4G 0.5G POWDER FOR SOLUTION Discontinued 2025-05-28 2025-05-28 258717

Showing 101 to 120 of 435